Early radiological assessment of locally advanced pancreatic cancer treated with electrochemotherapy

被引:1
|
作者
Vincenza Granata [1 ]
Roberta Fusco [1 ]
Sergio Venanzio Setola [1 ]
Mauro Piccirillo [2 ]
Maddalena Leongito [2 ]
Raffaele Palaia [2 ]
Francesco Granata [3 ]
Secondo Lastoria [1 ]
Francesco Izzo [2 ]
Antonella Petrillo [1 ]
机构
[1] Department of Diagnostic Imaging, Radiant and Metabolic Therapy, “Istituto Nazionale Tumori IRCCS Fondazione Pascale - IRCCS di Napoli”
[2] Department of Surgical Oncology, Hepatobiliary Unit, “Istituto Nazionale Tumori IRCCS Fondazione Pascale - IRCCS di Napoli”
[3] Departement of Civil and Mechanical Engineering, “University of Cassino and Southern Lazio”,Viale dell'Università
关键词
Reversible electroporation; Response assessment; Positron emission tomography/computed tomography; Pancreatic cancer; Magnetic resonance imaging;
D O I
暂无
中图分类号
R735.9 [胰腺肿瘤];
学科分类号
100214 ;
摘要
AIM To report early imaging assessment of ablated area post electrochemotherapy(ECT) in patients with locally advanced pancreatic cancer(LAPC). METHODS ECT was performed in 19 LAPC patients enrolled in an approved ongoing clinical phase Ⅰ/Ⅱ study. Before and after ECT, 18 patients underwent computed tomography(CT) scan, 11 patients underwent morphological and functional magnetic resonance(MR) scan(dynamic contrast enhanced-MRI) calculating wash-in slope(WIS) and wash-out slope(WOS); diffusion weighted imaging calculating pseudo-diffusivity(Dp), perfusion fraction(fp) and tissue diffusivity(Dt); 10 patients underwentpositron emission tomography(PET). Response evaluation criteria in solid tumour(RECIST) on MR and CT were used to assess tumour therapy response. Choi on CT, PET response criteria in solid tumors(PERCIST) on PET and functional parameters on MR were used to evaluate treatment response.RESULTS For each patient no significant reduction was measurable by CT and MR using RECIST. According Choi criteria a partial response was obtained in 18/18(100.0%) patients. According PERCIST criteria 6/10(60.0%) patients showed a partial response, 3/10(30.0%) stable disease and 1/10(10.0%) progression disease. Moreover, using functional MR parameters, a significant reduction of viable tumour after ECT can be observed. According ΔWIS and ΔWOS 9/11(81.8%) patients exhibited a partial response and 2/11(18.2%) stable disease; 8/11(72.7%) patients were considered in partial response by ΔDp evaluation and 3/11(27.3%) in stable disease; according ΔDt 7/11(63.6%) patients showed a partial response, 1/11(9.1%) showed progression of disease and 3/11(27.3%) were stable. Perfusion fraction fp showed a significant reduction after ECT only in four patients. No significant difference was observed after ECT in signal intensity of T1-weighted images and T2-weighted images, and in equilibrium-phase of contrast study, according to χ2 test was observed. A good correlation was reported between ΔHounsfield unit and Δmaximum standardized uptake value and between Δfp and ΔWOS, with a significant statistically difference(P < 0.05) using Spearman correlation coefficient.CONCLUSION Perfusion and diffusion MR derived parameters, Choi, PERCIST criteria are more performant than morphological MR and CT criteria to assess ECT treatment response.
引用
收藏
页码:4767 / 4778
页数:12
相关论文
共 50 条
  • [31] Chemoradiotherapy for locally advanced pancreatic cancer
    Diener, Markus K.
    Combs, Stephanie E.
    Buechler, Markus W.
    LANCET ONCOLOGY, 2013, 14 (04): : 269 - 270
  • [32] For the motion: locally advanced pancreatic cancer
    Huguet, F.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S346 - S346
  • [33] Locally advanced pancreatic cancer: A review
    Russo, Suzanne
    Butler, Jerome
    Ove, Roger
    Blackstock, A. William
    SEMINARS IN ONCOLOGY, 2007, 34 (04) : 327 - 334
  • [34] Cryosurgery for locally advanced pancreatic cancer
    Lyalkin, SA
    Litvinenko, AA
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S157 - S157
  • [35] Radiological and Surgical Implications of Neoadjuvant Treatment With FOLFIRINOX for Locally Advanced and Borderline Resectable Pancreatic Cancer
    Ferrone, Cristina R.
    Marchegiani, Giovanni
    Hong, Theodore S.
    Ryan, David P.
    Deshpande, Vikram
    McDonnell, Erin I.
    Sabbatino, Francesco
    Santos, Daniela Dias
    Allen, Jill N.
    Blaszkowsky, Lawrence S.
    Clark, Jeffrey W.
    Faris, Jason E.
    Goyal, Lipika
    Kwak, Eunice L.
    Murphy, Janet E.
    Ting, David T.
    Wo, Jennifer Y.
    Zhu, Andrew X.
    Warshaw, Andrew L.
    Lillemoe, Keith D.
    Fernandez-del Castillo, Carlos
    ANNALS OF SURGERY, 2015, 261 (01) : 12 - 17
  • [36] Intraoperative electrochemotherapy in locally advanced pancreatic cancer: Results and impact on quality of life. a single center experience.
    Di Marco, Mariacristiana
    Ricci, Claudio
    Carloni, Riccardo
    Grassi, Elisa
    De Lorenzo, Stefania
    Pallon, Andrea
    Abbati, Francesca
    Andrini, Elisa
    Di Federico, Alessandro
    Ricci, Angela Dalia
    Ingaldi, Carlo
    Serra, Carla
    Alberici, Laura
    De Raffele, Emilio
    Guido, Alessandro
    Minni, Francesco
    Rizo, Alessandro
    Brandi, Giovanni
    Panatleo, Maria A.
    Casadei, Riccardo
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [37] SHOULD ALL PATIENTS WITH LOCALLY ADVANCED PANCREATIC CANCER BE OFFERED INTRAOPERATIVE ASSESSMENT?
    Rao, V.
    Chantladze, K.
    Kugathasan, S.
    Byass, O.
    Razack, A.
    Wedgwood, K.
    GUT, 2012, 61 : A117 - A118
  • [38] Electrochemotherapy for Treatment of Locally Advanced Superficial Cancer: Results from a Single Institution
    Pennacchioli, E.
    Intelisano, A.
    Verrecchia, F.
    Tosti, G.
    Cocorocchio, E.
    Spadola, G.
    Ferrucci, P.
    Testori, A.
    ANNALS OF SURGICAL ONCOLOGY, 2013, 20 : S97 - S97
  • [39] Electrochemotherapy for Treatment of Locally Advanced Superficial Cancer: Results from a Single Institution
    Pennacchioli, E.
    Margarino, C.
    Verrecchia, F.
    Tosti, G.
    Spadola, G.
    Baldini, F.
    Mosconi, M.
    Ferrucci, P.
    Cataldo, F.
    Testori, A.
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 : S126 - S126
  • [40] Response evaluation of vessel involvement in locally advanced pancreatic cancer treated by neoadjuvant chemoradiation
    Ottensmeier, F.
    Goch, C. J.
    Liermann, J.
    Maier-Hein, K. H.
    Debus, J.
    Naumann, P.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2019, 195 : S193 - S193